Skip to main content

Test announcement

Announcement here about some event or update. Or maybe link to promoted article. 

Main navigation

  • Home
  • Culture
    • Humor
    • Mathematics
    • Random Thoughts
    • Science & Society
    • Sports Science
    • Technology
  • Earth Sciences
    • Atmospheric
    • Energy
    • Environment
    • Geology
    • Oceanography
    • Paleontology
  • Life Sciences
    • Ecology & Zoology
    • Evolution
    • Immunology
    • Microbiology
    • Neuroscience
  • Medicine
    • Aging
    • Cancer Research
    • Clinical Research
    • Pharmacology
    • Public Health
    • Vision
  • Physical Sciences
    • Aerospace
    • Applied Physics
    • Chemistry
    • Optics
    • Physics
    • Space
  • Social Sciences
    • Anthropology
    • Archaeology
    • Philosophy & Ethics
    • Psychology
    • Science History
  • Contributors
X XD

User menu

  • Log in
Cancer Research: Why Raf Sometimes Doesn't Switch Off

Cancer Research: Why Raf Sometimes Doesn't Switch Off

Cellular processes, such as when to multiply, are often regulated by switches that control the frequency and timing of interactions between proteins. North Carolina State University scientists have…
Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH

Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH

FRIMLEY, England, December 12 /PRNewswire/ -- - Approximately 78% of Beta-thalassaemia Patients had Decreases in Cardiac Iron and 90% had Decreases in Liver Iron After Six Months, Interim Data Show(…
Oncolytics Biotech Inc. Announces Issuance of 25th U.S. Patent

Oncolytics Biotech Inc. Announces Issuance of 25th U.S. Patent

CALGARY, Canada, December 11 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced that it has been granted U.S. Patent 7,306,902 entitled "Oncolytic…
FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208

FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208

CALGARY, Canada, December 10 /PRNewswire/ -- - New Class of ApoA-I/HDL Drugs to Reverse Atherosclerosis Enters the Clinic Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that it has…
ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc.

ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc.

HALIFAX, Canada, December 10 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT), a Nova Scotia-based vaccine enhancement company, has signed a binding memorandum of understanding to acquire…
Roche to Announce New Breast Cancer Data Pointing to Better Survival Chances and Potential for Cure

Roche to Announce New Breast Cancer Data Pointing to Better Survival Chances and Potential for Cure

BASEL, Switzerland, December 10 /PRNewswire/ -- - Phase II Results Suggest Avastin Can be Used in Curative Setting Date Experts attending the 30th San Antonio Breast Cancer Symposium (SABCS)…
EpiCept Releases New Data Demonstrating Prolonged Five-Year Leukemia-Free Survival for AML Patients Treated with Ceplene(TM) + I

EpiCept Releases New Data Demonstrating Prolonged Five-Year Leukemia-Free Survival for AML Patients Treated with Ceplene(TM) + I

TARRYTOWN, New York, December 10 /PRNewswire/ -- - First Drug Regimen Shown to Prevent AML Relapse EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today released new clinical data that…
Sometimes Epigenetic Multistability Is Nature's Friend

Sometimes Epigenetic Multistability Is Nature's Friend

One gene for pea pod color generates green pods while a variant of that gene gives rise to the yellow-pod phenotype, a feature that helped Gregor Mendel, the 19th century Austrian priest and…
Pharmion Presents Clinical Data Demonstrating Significant Survival Advantage of Azacitidine (Vidaza(R)) in Patients With Myelody

Pharmion Presents Clinical Data Demonstrating Significant Survival Advantage of Azacitidine (Vidaza(R)) in Patients With Myelody

ATLANTA, Georgia, December 9 /PRNewswire/ -- - Data Demonstrate 9.4 Month Median Overall Survival Benefit in Higher-risk MDS for Azacitidine Compared to Conventional Care Regimens (Log Rank p=0.0001…
Genetics Might Explain Why Schizophrenics Have Lower Cancer Rates

Genetics Might Explain Why Schizophrenics Have Lower Cancer Rates

A series of studies presented today at the American College of Neuropsychopharmacology (ACNP) annual meeting elucidates evidence that there is a genetic link between schizophrenia and cancer,…

Pagination

  • Previous page ← Prev
  • Page 115
  • Page 116
  • Page 117
  • Page 118
  • Current page 119
  • Page 120
  • Page 121
  • Page 122
  • Page 123
  • Next page Next →
Subscribe to Cancer Research

Donate

Please donate so science experts can write for the public.

At Science 2.0, scientists are the journalists, with no political bias or editorial control. We can't do it alone so please make a difference.

Donate with PayPal button 
We are a nonprofit science journalism group operating under Section 501(c)(3) of the Internal Revenue Code that's educated over 300 million people.

You can help with a tax-deductible donation today and 100 percent of your gift will go toward our programs, no salaries or offices.

More reads

Featured Image

Was Oumuamua A Solar Sail From An Alien Civilization That Flew Past Earth Last Year? Entertaining But Implausible Suggestion

Short summary: it's an entertaining but rather far fetched proposal in an arxiv preprint not published anywhere but mentioned in a Scientific American op ed. Implausible for many reasons including…
Featured Image

Top Quarks Observed In Proton-Nucleus Collisions For The First Time

The top quark is the heaviest known matter corpuscle we consider elementary. Elementary is an overloaded word in English, so I need to explain what it means in the context of subatomic particles. If…
Featured Image

Optimists Live 15% Longer

Scholars from  from Boston University School of Medicine), National Center for PTSD at VA Boston Healthcare System and Harvard T.H. Chan School of Public Health have used statistical correlation…
Featured Image

Melittin: Honeybee Venom Compound Kills Triple-Negative Breast Cancer Cells

The compound melittin, found in honeybee venom, rapidly destroyed triple-negative breast cancer and HER2-enriched breast cancer cells in a recent study.

Footer

  • About Us
  • Copyright and Removal
  • Privacy Policy
  • Terms